Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthstream (HSTM) Shares Outstanding (Weighted Average) (2016 - 2025)

Healthstream (HSTM) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $30.0 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) fell 1.21% to $30.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.0 million through Dec 2025, down 1.21% year-over-year, with the annual reading at $30.0 million for FY2025, 1.21% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $30.0 million at Healthstream, up from $29.7 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $31.5 million in Q3 2021, with the low at $29.7 million in Q3 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $30.7 million, with a median of $30.6 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) decreased 3.29% in 2022, then grew 0.48% in 2023.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $31.5 million in 2021, then fell by 2.81% to $30.6 million in 2022, then dropped by 0.25% to $30.6 million in 2023, then decreased by 0.61% to $30.4 million in 2024, then decreased by 1.21% to $30.0 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $30.0 million, $29.7 million, and $30.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.